[{"Assets_0_Q3_USD":1210213000.0,"CIK":"1706431","CommonStockSharesConverted_0_Q3_shares":130826122.0,"CommonStockSharesOutstanding_0_Q3_shares":130826122.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.85,"EarningsPerShareBasic_3_Q3_USD":0.03,"EarningsPerShareDiluted_1_Q3_USD":0.82,"EarningsPerShareDiluted_3_Q3_USD":0.02,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-55284000.0,"NetIncomeLossConverted_1_Q3_USD":110428000.0,"NetIncomeLossConverted_3_Q3_USD":3330000.0,"OfficialName":"Vir Biotechnology Inc. Common Stock","RevenuesConverted_1_Q3_USD":103616000.0,"RevenuesConverted_3_Q3_USD":282668000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":876274000.0,"Ticker":"VIR","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":133854419.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":133318979.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":130665831.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":129520837.0,"filed":"20211104","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20210930","qtrs":"1","uom":"USD"}]